{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:22:53Z","timestamp":1784071373687,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["PRELUDIUM 4, No UMO-2012\/07\/N\/NZ4\/02088"],"award-info":[{"award-number":["PRELUDIUM 4, No UMO-2012\/07\/N\/NZ4\/02088"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","award":["MNmb515\/2016"],"award-info":[{"award-number":["MNmb515\/2016"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00210-018-1572-7","type":"journal-article","created":{"date-parts":[[2018,10,28]],"date-time":"2018-10-28T21:28:06Z","timestamp":1540762086000},"page":"209-217","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro"],"prefix":"10.1007","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5251-7763","authenticated-orcid":false,"given":"Izabela","family":"Zakrocka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna M.","family":"Targowska-Duda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Wnorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Kocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"J\u00f3\u017awiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar A.","family":"Turski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,29]]},"reference":[{"key":"1572_CR1","doi-asserted-by":"publisher","first-page":"17454","DOI":"10.1074\/jbc.M114.568998","volume":"289","author":"MM Altintas","year":"2014","unstructured":"Altintas MM, Moriwaki K, Wei C, M\u00f6ller CC, Flesche J, Li J, Yaddanapudi S, Faridi MH, G\u00f6del M, Huber TB, Preston RA, Jiang JX, Kerjaschki D, Sever S, Reiser J (2014) Reduction of proteinuria through podocyte alkalinization. J Biol Chem 289:17454\u201317467. \n                    https:\/\/doi.org\/10.1074\/jbc.M114.568998","journal-title":"J Biol Chem"},{"key":"1572_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejphar.2014.09.020","volume":"743","author":"B B\u0105dzy\u0144ska","year":"2014","unstructured":"B\u0105dzy\u0144ska B, Zakrocka I, Sadowski J, Turski WA, Kompanowska-Jezierska E (2014) Effects of systemic administration of kynurenic acid and glycine on renal haemodynamics and excretion in normotensive and spontaneously hypertensive rats. Eur J Pharmacol 743:37\u201341. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2014.09.020","journal-title":"Eur J Pharmacol"},{"key":"1572_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1517\/14728222.2014.983900","volume":"19","author":"M Bozic","year":"2015","unstructured":"Bozic M, Valdivielso JM (2015) The potential of targeting NMDA receptors outside the CNS. Expert Opin Ther Targets 19:399\u2013413. \n                    https:\/\/doi.org\/10.1517\/14728222.2014.983900","journal-title":"Expert Opin Ther Targets"},{"key":"1572_CR4","doi-asserted-by":"publisher","first-page":"29330","DOI":"10.1074\/jbc.270.49.29330","volume":"270","author":"R Buchli","year":"1995","unstructured":"Buchli R, Alberati-Giani D, Malherbe P, K\u00f6hler C, Broger C, Cesura AM (1995) Cloning and functional expression of a soluble form of kynurenine\/alpha-aminoadipate aminotransferase from rat kidney. J Biol Chem 270:29330\u201329335","journal-title":"J Biol Chem"},{"key":"1572_CR5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/978-1-4615-4709-9_80","volume":"467","author":"CV Costa","year":"1999","unstructured":"Costa CV, Ragazzi E, Caparrotta L et al (1999) Liver and kidney kynurenine aminotransferase activity in different strains of rats. Adv Exp Med Biol 467:629\u2013635","journal-title":"Adv Exp Med Biol"},{"key":"1572_CR6","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/ndt\/gfv028","volume":"30","author":"SE Dryer","year":"2015","unstructured":"Dryer SE (2015) Glutamate receptors in the kidney. Nephrol Dial Transplant 30:1630\u20131638. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfv028","journal-title":"Nephrol Dial Transplant"},{"key":"1572_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/ki.2011.306","volume":"81","author":"A Fukuda","year":"2012","unstructured":"Fukuda A, Wickman LT, Venkatareddy MP, Sato Y, Chowdhury MA, Wang SQ, Shedden KA, Dysko RC, Wiggins JE, Wiggins RC (2012) Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int 81:40\u201355. \n                    https:\/\/doi.org\/10.1038\/ki.2011.306","journal-title":"Kidney Int"},{"key":"1572_CR8","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1681\/ASN.2008121286","volume":"20","author":"L Giardino","year":"2009","unstructured":"Giardino L, Armelloni S, Corbelli A, Mattinzoli D, Zennaro C, Guerrot D, Tourrel F, Ikehata M, Li M, Berra S, Carraro M, Messa P, Rastaldi MP (2009) Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier. J Am Soc Nephrol 20:1929\u20131940. \n                    https:\/\/doi.org\/10.1681\/ASN.2008121286","journal-title":"J Am Soc Nephrol"},{"key":"1572_CR9","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.2215\/CJN.02560317","volume":"12","author":"ME Grams","year":"2017","unstructured":"Grams ME, Tin A, Rebholz CM, Shafi T, K\u00f6ttgen A, Perrone RD, Sarnak MJ, Inker LA, Levey AS, Coresh J (2017) Metabolomic alterations associated with cause of CKD. Clin J Am Soc Nephrol 12:1787\u20131794. \n                    https:\/\/doi.org\/10.2215\/CJN.02560317","journal-title":"Clin J Am Soc Nephrol"},{"key":"1572_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(92)91337-E","volume":"588","author":"JBP Gramsbergen","year":"1992","unstructured":"Gramsbergen JBP, Schmidt W, Turski WA, Schwarcz R (1992) Age-related changes in kynurenic acid production in rat brain. Brain Res 588:1\u20135. \n                    https:\/\/doi.org\/10.1016\/0006-8993(92)91337-E","journal-title":"Brain Res"},{"key":"1572_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/(SICI)1097-4547(19971101)50:3<457::AID-JNR12>3.0.CO;2-3","volume":"50","author":"P Guidetti","year":"1997","unstructured":"Guidetti P, Okuno E, Schwarcz R (1997) Characterization of rat brain kynurenine aminotransferases I and II. J Neurosci Res 50:457\u2013465. \n                    https:\/\/doi.org\/10.1002\/(SICI)1097-4547(19971101)50:3<457::AID-JNR12>3.0.CO;2-3","journal-title":"J Neurosci Res"},{"key":"1572_CR12","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1074\/jbc.M708358200","volume":"283","author":"Q Han","year":"2008","unstructured":"Han Q, Robinson H, Li J (2008) Crystal structure of human kynurenine aminotransferase II. J Biol Chem 283:3567\u20133573. \n                    https:\/\/doi.org\/10.1074\/jbc.M708358200","journal-title":"J Biol Chem"},{"key":"1572_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2008\/420747","volume":"2008","author":"T Hruz","year":"2008","unstructured":"Hruz T, Laule O, Szabo G, Wessendorp F, Bleuler S, Oertle L, Widmayer P, Gruissem W, Zimmermann P (2008) Genevestigator V3: a reference expression database for the meta-analysis of transcriptomes. Adv Bioinforma 2008:1\u20135. \n                    https:\/\/doi.org\/10.1155\/2008\/420747","journal-title":"Adv Bioinforma"},{"key":"1572_CR14","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/jfd.12567","volume":"40","author":"E Kaczorek","year":"2017","unstructured":"Kaczorek E, Szarek J, Mikiewicz M, Terech-Majewska E, Schulz P, Ma\u0142aczewska J, W\u00f3jcik R, Siwicki AK (2017) Effect of feed supplementation with kynurenic acid on the morphology of the liver, kidney and gills in rainbow trout (Oncorhynchus mykiss Walbaum, 1792), healthy and experimentally infected with Yersinia ruckeri. J Fish Dis 40:873\u2013884. \n                    https:\/\/doi.org\/10.1111\/jfd.12567","journal-title":"J Fish Dis"},{"key":"1572_CR15","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1080\/00498254.2017.1384079","volume":"48","author":"Y Kato","year":"2017","unstructured":"Kato Y, Mukai Y, Rane A, Inotsume N, Toda T (2017) Combined effect of telmisartan and fluvastatin on arachidonic acid metabolism in human liver microsomes. Xenobiotica 48:898\u2013903. \n                    https:\/\/doi.org\/10.1080\/00498254.2017.1384079","journal-title":"Xenobiotica"},{"key":"1572_CR16","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.2174\/1381612811319170009","volume":"19","author":"H Kobori","year":"2013","unstructured":"Kobori H, Mori H, Masaki T, Nishiyama A (2013) Angiotensin II blockade and renal protection. Curr Pharm Des 19:3033\u20133042. \n                    https:\/\/doi.org\/10.2174\/1381612811319170009","journal-title":"Curr Pharm Des"},{"key":"1572_CR17","doi-asserted-by":"publisher","unstructured":"Lin CS, Hung SF, Huang HS, Ma MC (2015) Blockade of the N-methyl-D-aspartate glutamate receptor ameliorates lipopolysaccharide-induced renal insufficiency. PLoS One. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0132204","DOI":"10.1371\/journal.pone.0132204"},{"key":"1572_CR18","doi-asserted-by":"publisher","unstructured":"Li H, Zhao JL, Zhang YM, Han SX (2018) Inhibitory effects of candesartan on KCa3.1 potassium channel expression and cell culture and proliferation in peripheral blood CD4+T lymphocytes in Kazakh patients with hypertension from the Xinjiang region. Clin Exp Hypertens. \n                    https:\/\/doi.org\/10.1080\/10641963.2017.1377212","DOI":"10.1080\/10641963.2017.1377212"},{"key":"1572_CR19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s13105-016-0514-4","volume":"72","author":"Z Miloradovi\u0107","year":"2016","unstructured":"Miloradovi\u0107 Z, Ivanov M, Jovovi\u0107 \u0110, Karanovi\u0107 D, Vaji\u0107 UJ, Markovi\u0107-Lipkovski J, Mihailovi\u0107-Stanojevi\u0107 N, Milanovi\u0107 JG (2016) Angiotensin 2 type 1 receptor blockade different affects postishemic kidney injury in normotensive and hypertensive rats. J Physiol Biochem 72:813\u2013820. \n                    https:\/\/doi.org\/10.1007\/s13105-016-0514-4","journal-title":"J Physiol Biochem"},{"key":"1572_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1023\/A:1015238418500","volume":"33","author":"D Pawlak","year":"2001","unstructured":"Pawlak D, Pawlak K, Malyszko J, Mysliwiec M, Buczko W (2001a) Accumulation of toxic products degradation of kynurenine in hemodialyzed patients. Int Urol Nephrol 33:399\u2013404. \n                    https:\/\/doi.org\/10.1023\/A:1015238418500","journal-title":"Int Urol Nephrol"},{"key":"1572_CR21","first-page":"755","volume":"52","author":"D Pawlak","year":"2001","unstructured":"Pawlak D, Tankiewicz A, Buczko W (2001b) Kynurenine and its metabolites in the rat with experimental renal insufficiency. J Physiol Pharmacol 52:755\u2013766","journal-title":"J Physiol Pharmacol"},{"key":"1572_CR22","first-page":"175","volume":"54","author":"D Pawlak","year":"2003","unstructured":"Pawlak D, Tankiewicz A, Matys T, Buczko W (2003) Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure. J Physiol Pharmacol 54:175\u2013189","journal-title":"J Physiol Pharmacol"},{"key":"1572_CR23","first-page":"98","volume":"47","author":"VN Perfilova","year":"2016","unstructured":"Perfilova VN, Tyurenkov IN (2016) Glutamate Metabotropic Receptors: Structure, Localisation. Functions Usp Fiziol Nauk 47:98\u2013112","journal-title":"Functions Usp Fiziol Nauk"},{"key":"1572_CR24","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jss.2013.01.040","volume":"183","author":"M Pundir","year":"2013","unstructured":"Pundir M, Arora S, Kaur T, Singh R, Singh AP (2013) Effect of modulating the allosteric sites of N-methyl-D-aspartate receptors in ischemia-reperfusion induced acute kidney injury. J Surg Res 183:668\u2013677. \n                    https:\/\/doi.org\/10.1016\/j.jss.2013.01.040","journal-title":"J Surg Res"},{"key":"1572_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/1753944715585512","volume":"9","author":"R Satou","year":"2015","unstructured":"Satou R, Shao W, Navar LG (2015) Role of stimulated intrarenal angiotensinogen in hypertension. Ther Adv Cardiovasc Dis 9:181\u2013190. \n                    https:\/\/doi.org\/10.1177\/1753944715585512","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"1572_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2017.11.001","volume":"369","author":"C Song","year":"2018","unstructured":"Song C, Clark SM, Vaughn CN, Nicholson JD, Murphy KJ, Mou TCM, Schwarcz R, Hoffman GE, Tonelli LH (2018) Quantitative analysis of kynurenine aminotransferase II in the adult rat brain reveals high expression in proliferative zones and corpus callosum. Neuroscience 369:1\u201314. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2017.11.001","journal-title":"Neuroscience"},{"key":"1572_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0014-2999(02)01851-4","volume":"447","author":"TW Stone","year":"2002","unstructured":"Stone TW, Addae JI (2002) The pharmacological manipulation of glutamate receptors and neuroprotection. Eur J Pharmacol 447:285\u2013296. \n                    https:\/\/doi.org\/10.1016\/S0014-2999(02)01851-4","journal-title":"Eur J Pharmacol"},{"key":"1572_CR28","doi-asserted-by":"publisher","unstructured":"Weir MR (2017) Acute changes in glomerular filtration rate with renin-angiotensin system (RAS) inhibition: clinical implications. Kidney Int 91:529\u2013531. \n                    https:\/\/doi.org\/10.1016\/j.kint.2016.11.019","DOI":"10.1016\/j.kint.2016.11.019"},{"key":"1572_CR29","doi-asserted-by":"publisher","first-page":"6919","DOI":"10.1128\/MCB.24.16.6919-6930.2004","volume":"24","author":"P Yu","year":"2004","unstructured":"Yu P, Di Prospero NA, Sapko MT et al (2004) Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice. Mol Cell Biol 24:6919\u20136930. \n                    https:\/\/doi.org\/10.1128\/MCB.24.16.6919-6930.2004","journal-title":"Mol Cell Biol"},{"key":"1572_CR30","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ejphar.2016.07.023","volume":"789","author":"I Zakrocka","year":"2016","unstructured":"Zakrocka I, Turski WA, Kocki T (2016) Angiotensin-converting enzyme inhibitors modulate kynurenic acid production in rat brain cortex in vitro. Eur J Pharmacol 789:308\u2013312. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2016.07.023","journal-title":"Eur J Pharmacol"},{"key":"1572_CR31","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.pharep.2017.01.023","volume":"69","author":"I Zakrocka","year":"2017","unstructured":"Zakrocka I, Kocki T, Turski WA (2017a) The effect of three angiotensin-converting enzyme inhibitors on kynurenic acid production in rat kidney in vitro. Pharmacol Reports 69:536\u2013541. \n                    https:\/\/doi.org\/10.1016\/j.pharep.2017.01.023","journal-title":"Pharmacol Reports"},{"key":"1572_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s12640-017-9781-2","volume":"32","author":"I Zakrocka","year":"2017","unstructured":"Zakrocka I, Targowska-Duda KM, Wnorowski A, Kocki T, J\u00f3\u017awiak K, Turski WA (2017b) Angiotensin II type 1 receptor blockers inhibit KAT II activity in the brain\u2014its possible clinical applications. Neurotox Res 32:639\u2013648. \n                    https:\/\/doi.org\/10.1007\/s12640-017-9781-2","journal-title":"Neurotox Res"},{"key":"1572_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11906-017-0771-9","volume":"19","author":"F Zhang","year":"2017","unstructured":"Zhang F, Liu H, Liu D, Liu Y, Li H, Tan X, Liu F, Peng Y, Zhang H (2017) Effects of RAAS inhibitors in patients with kidney disease. Curr Hypertens Rep 19:72. \n                    https:\/\/doi.org\/10.1007\/s11906-017-0771-9","journal-title":"Curr Hypertens Rep"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-018-1572-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-018-1572-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-018-1572-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T20:12:32Z","timestamp":1572293552000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-018-1572-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,29]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1572"],"URL":"https:\/\/doi.org\/10.1007\/s00210-018-1572-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,29]]},"assertion":[{"value":"26 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the I Local Ethics Committee for Animal Experiments in Lublin, Poland.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}